Companies

Bristol Myers Squibb

Bristol Myers Squibb is a global biopharma leader in immuno-oncology, hematology, and cardiovascular disease. Its checkpoint inhibitor and CAR-T cell therapy programs grew from extensive academic partnerships and translational research.

Details

Industry

Biopharma

R&D Spend

$9.3B